| Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy G Ceccon, P Lohmann, G Stoffels, N Judov, CP Filss, M Rapp, E Bauer, ... Neuro-oncology 19 (2), 281-288, 2017 | 166 | 2017 |
| Radiomics in neuro-oncology: Basics, workflow, and applications P Lohmann, N Galldiks, M Kocher, A Heinzel, CP Filss, C Stegmayr, ... Methods 188, 112-121, 2021 | 136 | 2021 |
| Current status of PET imaging in neuro-oncology N Galldiks, P Lohmann, NL Albert, JC Tonn, KJ Langen Neuro-Oncology Advances 1 (1), vdz010, 2019 | 131 | 2019 |
| Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis P Lohmann, M Kocher, G Ceccon, EK Bauer, G Stoffels, S Viswanathan, ... NeuroImage: Clinical 20, 537-542, 2018 | 131 | 2018 |
| Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[18F] fluoroethyl)-L-tyrosine (FET) KJ Langen, G Stoffels, C Filss, A Heinzel, C Stegmayr, P Lohmann, ... Methods 130, 124-134, 2017 | 130 | 2017 |
| Applications of radiomics and machine learning for radiotherapy of malignant brain tumors M Kocher, MI Ruge, N Galldiks, P Lohmann Strahlentherapie und Onkologie 196, 856-867, 2020 | 129 | 2020 |
| Predicting IDH genotype in gliomas using FET PET radiomics P Lohmann, C Lerche, EK Bauer, J Steger, G Stoffels, T Blau, V Dunkl, ... Scientific reports 8 (1), 13328, 2018 | 114 | 2018 |
| Static and dynamic 18F–FET PET for the characterization of gliomas defined by IDH and 1p/19q status A Verger, G Stoffels, EK Bauer, P Lohmann, T Blau, GR Fink, B Neumaier, ... European Journal of Nuclear Medicine and Molecular Imaging 45 (3), 443-451, 2018 | 112 | 2018 |
| Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase 18F-FET PET accuracy … P Lohmann, G Stoffels, G Ceccon, M Rapp, M Sabel, CP Filss, MA Kamp, ... European radiology 27, 2916-2927, 2017 | 107 | 2017 |
| FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma P Lohmann, P Stavrinou, K Lipke, EK Bauer, G Ceccon, JM Werner, ... European journal of nuclear medicine and molecular imaging 46, 591-602, 2019 | 105 | 2019 |
| Dual-time-point O-(2-[18F] fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas P Lohmann, H Herzog, E Rota Kops, G Stoffels, N Judov, C Filss, ... European radiology 25 (10), 3017-3024, 2015 | 91 | 2015 |
| FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation P Lohmann, MA Elahmadawy, R Gutsche, JM Werner, EK Bauer, ... Cancers 12 (12), 3835, 2020 | 87 | 2020 |
| Bone regeneration induced by a 3D architectured hydrogel in a rat critical-size calvarial defect P Lohmann, A Willuweit, AT Neffe, S Geisler, TP Gebauer, S Beer, ... Biomaterials 113, 158-169, 2017 | 82 | 2017 |
| Radiomics in radiation oncology—basics, methods, and limitations P Lohmann, K Bousabarah, M Hoevels, H Treuer Strahlentherapie und Onkologie 196 (10), 848-855, 2020 | 81 | 2020 |
| Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients P Lohmann, JM Werner, NJ Shah, GR Fink, KJ Langen, N Galldiks Cancers 11 (2), 153, 2019 | 70 | 2019 |
| Comparison of 18F-FET PET and perfusion-weighted MRI for glioma grading: a hybrid PET/MR study A Verger, CP Filss, P Lohmann, G Stoffels, M Sabel, HJ Wittsack, ER Kops, ... European Journal of Nuclear Medicine and Molecular Imaging 44 (13), 2257-2265, 2017 | 69 | 2017 |
| Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI JM Werner, G Stoffels, T Lichtenstein, J Borggrefe, P Lohmann, G Ceccon, ... European journal of nuclear medicine and molecular imaging 46, 1889-1901, 2019 | 66 | 2019 |
| Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine N Galldiks, V Dunkl, G Ceccon, C Tscherpel, G Stoffels, I Law, ... European journal of nuclear medicine and molecular imaging 45, 2377-2386, 2018 | 60 | 2018 |
| Influence of Bevacizumab on Blood–Brain Barrier Permeability and O-(2-18F-Fluoroethyl)-l-Tyrosine Uptake in Rat Gliomas C Stegmayr, D Oliveira, N Niemietz, A Willuweit, P Lohmann, N Galldiks, ... Journal of Nuclear Medicine 58 (5), 700-705, 2017 | 52 | 2017 |
| PET/MRI radiomics in patients with brain metastases P Lohmann, M Kocher, MI Ruge, V Visser-Vandewalle, NJ Shah, GR Fink, ... Frontiers in neurology 11, 1, 2020 | 50 | 2020 |
Norbert GalldiksProfessor of Neurology, University Hospital Cologne & Research Center Juelich (INM-3)Верификована је имејл адреса на uk-koeln.de